San Jose, California, 24 January 2023 – Complete Genomics Inc., a global life science tools leader and a subsidiary of MGI Tech Co., Ltd. (MGI), today announced plans to launch three new products at the Advances in Genome Biology and Technology (AGBT) General Meeting, taking place from 6–9 February in Hollywood, Florida.
The new launches include an ultra-high-speed sequencer with mid- to low-throughput capability, an ultra-high-throughput sequencing system and a novel library preparation kit designed for long-fragment sequencing.
“We are excited to unveil our new massively parallel next-generation sequencing products at this year’s AGBT meeting,” said Rade Drmanac, PhD, Chief Scientific Officer of Complete Genomics.
“Over the years, our products have empowered customers and partners worldwide in both scientific research and clinical applications. We now look forward to introducing these new offerings, backed by our state-of-the-art technologies, to expand sequencing capacity, accelerate breakthroughs in life science and healthcare, and support molecular health monitoring, early disease detection and prevention.”
Advancing Sequencing with DNBSEQ™ Technology
Complete Genomics continues to advance life science innovation through a product portfolio built on its highly efficient and accurate core technology, DNBSEQ™. The company offers high-quality genetic sequencers supporting applications across low-, medium- and ultra-high-throughput sequencing.
Its multi-omics platforms span the full workflow, from sample and library preparation through to downstream bioinformatics, alongside complementary capabilities in medical imaging and laboratory automation.
AGBT 2023
AGBT is the leading genome science and technology conference, bringing together laboratory heads, academic institutions, industry leaders, investors and other senior stakeholders to advance the field and drive transformative innovation.
Complete Genomics looks forward to participating in this important forum, where major scientific advances are announced, strategic partnerships are formed and significant investments and acquisitions take shape.
Meet Complete Genomics at AGBT
Visitors are invited to the Complete Genomics Suite #318 to learn more about the company’s DNBSEQ™ sequencing and laboratory automation platforms and to see live demonstrations of its newest products.
Complete Genomics will also host the following activities during AGBT:
- Breakfast hall: 7 February, 07:30–09:00 – registration and raffles
- Cocktail reception: 7 February, 17:00–19:15
- Suite talks: 7–9 February, 08:00–09:00 – product overviews and demonstrations
About Complete Genomics
Complete Genomics Inc., a subsidiary of MGI Tech Co., Ltd., is a global life science company offering laboratory automation and a comprehensive high-throughput sequencing product portfolio. Founded in June 2005 and headquartered in San Jose, California, the company operates a local demo laboratory and full supply centre with reagents, automation equipment and sequencers stored on site for customer access.
Complete Genomics released its first next-generation sequencing system, the DNBSEQ-G400C*, in the US in August 2022, followed by the DNBSEQ-T7* and DNBSEQ-T10×4* platforms in January 2023. Full specifications are available on the Complete Genomics website.
*Unless otherwise stated, StandardMPS and CoolMPS sequencing reagents, and sequencers compatible with these reagents, are not available in Germany, Spain, the UK, Sweden, Belgium, Italy, Finland, the Czech Republic, Switzerland, Portugal, Austria and Romania. StandardMPS products are not available in Hong Kong.
*Products are for Research Use Only. Not for use in diagnostic procedures.
Contacts
Shani Lewis
Assistant Vice President, Media
LaVoieHealthScience
Tel: +1 617 865 5554
Email: slewis@lavoiehealthscience.com
Dada Zhang
Senior Public Relations Manager
Complete Genomics
Email: zhangling8@mgi-tech.com
